Techcyte, developer of the Fusion unified digital pathology platform, and Biobase, creator of an agentic data discovery platform for connecting multi-modal clinical data to pharma and research buyers, ...

March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial intelligence (AI) tool that enhances pathology workflows by analysing whole ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

Roche has agreed to acquire PathAI, a Boston-based digital pathology firm, for up to $1.05 billion. Roche plans to pay $750 million upfront and up to $300 million in additional milestone payments, ...

The test imputes risk of metastasis in early-stage hormone receptor-positive, HER2-negative breast cancers to help tailor treatment.

QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...

Waiv will apply its end-to-end computational pathology platform to early phase data, including tumor microenvironment analysis and biomarker discovery.

I have been using the Soft-ECC® sampler for over a decade at different clinical institutions. It reliably picks up ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

Alpenglow Biosciences today announced Summit AI, its multimodal AI platform designed to analyze whole tissue volumes and convert complex imaging data into quantitative spatial rea ...

The Department of Pathology at University Hospitals Cleveland Medical Center, in collaboration with Case Western Reserve University (CWRU) School of Medicine has a long history and strong tradition of ...